繁荣或衰退:对虫和其他B细胞介导的自身免疫疾病的临床试验

Chuda Rujitharanawong1, Victoria P Werth2, Aimee S Payne3

  • 1Department of Dermatology, Columbia University, New York, New York, USA; Department of Dermatology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand and.

概括

对于pemphigus vulgaris (PV) 的治疗开发面临挑战,B细胞疗法如rituximab,efgartigimod和rilzabrutinib在自身免疫性疾病中的混合成功证明了这一点.